TRANSITION, SEPARATION AND RELEASE OF CLAIMS AGREEMENTConsulting Agreement • July 17th, 2019 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Transition, Separation and Release of Claims Agreement (the “Agreement”) is being provided to Daryl C. Drummond (“Executive”) on June 14, 2019 (the “Receipt Date”) and is made as of the Agreement Effective Date (as defined below) by and between Executive and Merrimack Pharmaceuticals, Inc. (the “Company”) (together, the “Parties”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 17th, 2019 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Stock Purchase Agreement (this “Agreement”) is made and entered into as of May 7, 2019 (the “Effective Date”) by and among HNKK Holdings Limited, a company registered in the British Virgin Islands (“Purchaser”), Merrimack Pharmaceuticals, Inc., a Delaware corporation (“Seller”), and Silver Creek Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
SEPARATION AND RELEASE OF CLAIMS AGREEMENTSeparation and Release of Claims Agreement • July 17th, 2019 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Separation and Release of Claims Agreement (the “Agreement”) is made as of the Effective Date (as defined below) between Merrimack Pharmaceuticals, Inc. (the “Company”) and Sergio L. Santillana (“Executive”) (together, the “Parties”).
